Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by WarrantOfficeron Sep 19, 2024 8:43am
61 Views
Post# 36230614

RE:A Great New Add to the Executive Team

RE:A Great New Add to the Executive TeamPerhaps Dr Iryna Sarachova is the missing fullerene element to compliment the members of Voyageurs highly skilled Scientific Advisory Board:

Deborah A. Baumgarten, MD, MPH

  • Professor of Radiology, Mayo Clinic, Jacksonville, Fl.
  • Fellow, Mayo Clinic, Academy of Academic Excellence
  • Educational Liaison for Abdominal CT Rotation
  • Interests: Gastrointestinal and Genitourinary conditions utilizing CT, US and Fluoro with a focus on cancer

Dr. Sat Somers MB ChB (Sheffield)

  • Professor of Radiology, McMaster University Medical Center, Hamilton, Ontario
  • Former Academic Head and Chairman, Department of Radiology, McMaster University Medical Center
  • QA Officer, Wentworth-Halton X-Ray & Ultrasound
  • Coordinator, Visiting Professor Program, McMaster University, Department of Radiology
  • Interests: Abdominal Radiology and Mammography, with research interests in Swallowing Problems, Small Bowel, and Pelvic Floor Abnormalities, and a special interest in barium contrast agents.

Alec J. Megibow, MD

  • Professor, Department of Radiology, NYU Grossman School of Medicine
  • Professor, Department of Surgery, NYU Grossman School of Medicine
  • Director, FPO Outpatient Imaging Services, NYU Langone Health
  • Interests: CT and MRI, liver, pancreas, and alimentary tract

C. Daniel Johnson, MD

  • Professor of Radiology, Mayo College of Medicine and Science
  • Consultant, Department of Radiology, Mayo Clinic, Scottsdale AZ.
  • Consultant, Department of Radiology, Mayo Clinic, Rochester, MN
  • Adjunct Faculty, College of Health Solutions, Arizona State University.
  • Interests: Full structural colorectal screening examination using CT Colonography. Includes exam performance, patient acceptance, cost effectiveness, image display technology, software and CT technology.

Thomas Lauenstein, MD

  • Medical Director, Evangelical Hospital, Dsseldorf, Germany
  • Interventional Radiology for oncology (SIRT/TACE)
  • Interests: Abdominal imaging with a focus on liver, pancreas and bowel. Hybrid imaging (PET/CT) and (PET/MRI)
<< Previous
Bullboard Posts
Next >>